| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Event features Monogram's mBôs commercial robot alongside panel of orthopaedic surgeons
AUSTIN, TX / ACCESSWIRE / February 12, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical robotics, hosted a recorded discussion of features of Monogram's mBôs and mVision technologies with a surgeon panel. Monogram's mVision technology is a novel approach to registration and tracking that the company is now working on for integration into the mBôs surgical robotic system in the future.
Below is an excerpt from the closing portion of the discussion and the product video that was played for the surgeon panel. The full discussion will be available separately via the registration link provided below.
Link: https://youtu.be/rnA6rwQbrIU
Ben Sexson, Chief Executive Officer, will present during the 2024 Canaccord Genuity Musculoskeletal Conference before attending the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting taking place February 12-16, 2024, in San Francisco.
Please use the link below to register to access a webcast of the full technical discussion of the mBôs and mVision technology suite with the surgeon panel.
Monogram Product Discussion Webcast
Date: Wednesday, February 21, 2024
Time: 11:00 a.m. CST
Webcast: https://streamyard.com/watch/AqQf7Hut8mVN
The AAOS Annual Meeting is the largest and most comprehensive orthopaedic educational experience in the world. Orthopaedic professionals from around the globe attend in pursuit of the latest clinical, scientific, surgical technology and practice management knowledge and expertise. To learn more, visit https://www.aaos.org/annual/.
Posted In: MGRM
